title: The proportion of CD34(+)CD38(low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnosed acute myeloid leukemia.
authors.forename: M
authors.initials: M
authors.lastname: Roshal
authors.forename: S
authors.initials: S
authors.lastname: Chien
authors.forename: M
authors.initials: M
authors.lastname: Othus
authors.forename: B L
authors.initials: BL
authors.lastname: Wood
authors.forename: M
authors.initials: M
authors.lastname: Fang
authors.forename: F R
authors.initials: FR
authors.lastname: Appelbaum
authors.forename: E H
authors.initials: EH
authors.lastname: Estey
authors.forename: T
authors.initials: T
authors.lastname: Papayannopoulou
authors.forename: P S
authors.initials: PS
authors.lastname: Becker
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000378:metabolism*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D018952:Antigens, CD34 / Q000378:metabolism*; D001752:Blast Crisis / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D016022:Case-Control Studies; D003131:Combined Modality Therapy; D020732:Cytogenetic Analysis; D005260:Female; D005434:Flow Cytometry; D042381:Granulocyte Precursor Cells / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D008297:Male; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D008875:Middle Aged; D011379:Prognosis; D015375:Receptors, Interleukin-2 / Q000502:physiology; D012074:Remission Induction; D055815:Young Adult
chemical_list: D018952:Antigens, CD34; D015375:Receptors, Interleukin-2; D051997:ADP-ribosyl Cyclase 1